The interaction between paracetamol molecule and graphene sheet and the influence of torsional deformation on it were studied on the basis of density functional theory. Our results show that paracetamol molecule is physically adsorbed on the graphene sheet in a parallel adsorption model. Torsional deformation can change the bonding strength between paracetamol and graphene sheet, so by adjusting the deformation, the sustained and controlled release of drugs may be achieved. The results of global reactivity descriptors show that the stability of paracetamol-graphene complex is reduced by the presence of graphene, but the chemical activity is improved. The effect of torsional deformation is opposite to that of graphene. The paracetamol-graphene complex is easy to bond with electrophilic groups. The increased strain decreases the electrophilic ability of paracetamol-graphene complex. Analysis confirms that global reactivity descriptors have reasonably good correlation with the solubility and dispersion of paracetamol graphene complex,but they cannot be used to determine the pharmacological activity of drugs. Analysis of frontier orbitals and Fukui indices suggests that the active sites of the paracetamol include benzene rings, phenolic hydroxyl groups (electrophilic active site) and carbonyl group (both the nucleophilic and electrophilic active sites). For paracetamol-graphene complex, the active sites are mainly distributed from the graphene, there is almost no the active sites distribution on the paracetamol molecule. Hence, we can deduce that paracetamol will not exert its efficacy before it dissolves from the paracetamol-graphene complex, as a result, the efficacy of the paracetamol can be controlled by graphene carriers.
Introduction
Paracetamol (PCT) is a common antipyretic analgesic drug, it is usually used in the treatment of colds, fever, headache, joint pain and pain after surgery in clinic. However, PCT has a short biological half-life, then a peak and valley phenomenon of drug concentration in blood will occur. Long-term use of PCT can cause gastric mucosal damage, renal dysfunction and other adverse reactions. The high concentration hydroxylated metabolites of PCT in vivo can damage liver and lead to liver coma or even death [1] . In order to decrease the side effects of PCT, a sustained and controlled release of PCT is need to be prepared.
Developing new drug delivery systems to improve the efficacy of drugs is one of the key issues we are facing in modern medicine. With advances in nanotechnology, many new nanopharmaceutical carriers have been developed [2] [3] [4] . Graphene with a honeycomb lattice has extraordinary physical and chemical properties, such as high specific surface area, excellent electric conductivity, low toxicity and good biocompatibility. Therefore, graphene has attracted great interest in the scientific community. Graphene has been widely used in nanoelectronic devices, nanocomposites, biomedical [5, 6] and other fields. As a drug delivery carrier, graphene sheets possess large assessible surface, leading to excellent ability to immobilize drug molecules [7] . In addition, graphene can be modified with functional group. The loading ratio of graphene oxide (GO) can be reached by 200%. Graphene derivatives and graphene composites have an extremely high drug loading and can increase the solubility of the drug in water and improve the targeted therapy of drug molecules [8, 9] . In short, graphene can be potentially used for drugs sustained and controlled release and targeted cancer therapy.
Graphene has been widely concerned in the biomedical field. There are many reports on the application of its drug carrier. However, the nature of the interaction between drug molecules and graphene are not clear, the related theoretical research is still limited, which limits the application of graphene in the field of medicine. As a drug carrier, the drug loading ratio should be high enough. Apart from that, it also hopes to achieve the purpose of slow release and targeted therapy. Defects can change the electronic and chemical properties of graphene. In this paper, we study the effect of torsional deformation on the interaction between the paracetamol and graphene system, in order to provide theoretical guidance for graphene to achieve sustained and controlled release as a carrier of paracetamol.
Computation Method and Models

Calculation Method
The interaction between PCT and graphene surface is calculated by the Dmol3 module based on density functional theory (DFT) in the MS6.0 software package [10] . The PBE approach of generalized gradient approximation (GGA) was used to deal with the exchange correlation potential [11] . The applied basis set was double numerical basis set with polarized orbital (DNP). The double numerical basis set with polarization function (DNP) is equivalent to 6-31G**basis set of Gaussian basis set. The self-consistent energy was converged to within 1×10 -6 hartreee (1hartree=27.21eV). The convergence criteria for the geometric optimization and energy calculation were set to: a maximum force tolerance of 2×10 -3 Ha/Å, a maximum displacement tolerance of displacement of 5×10 -3 Å, and an energy tolerance of 1×10 -5 Ha /atom.
Models+
Graphene has been represented as a supercell with a slab of 4× 4×1 sheet (30 C atoms), as shown in Fig.1(a) , all peripheral bonds of C atoms are saturated by H atoms. The molecular structure of PCT is shown in Fig.1b . Four models of interaction of CPT onto pristine graphene surface (Fig.2) . In model 1, 2 and3( Fig.2(a) , Fig.2(b) and Fig.2(c) ), PCT molecules are perpendicular to the surface of graphene oriented by the OH group, CH 3 groupand the H atoms toward it. The model4 shows PCT parallelly to the surface of the graphene. In order to investigate the effect of the torsional deformation on the PCT-graphene complex, the torsional strain was applied to the graphene sheet. Fig.1a presents the geometry of the graphene sheet lying in X-Y plane with no deformation. The seven C atoms and their connected H atoms on the left side of the graphene sheet were twisted counterclockwise about an axis (parallel to X-axis) passing through the center of the graphene sheet at an angle of 5 °, 10 °, 15 °, 20 °; Similarly, the seven C atoms and their connected H atoms on the right side of were clockwise rotated of the same degree. During optimization, the atoms selected in the first two steps were fixed, other C and H atoms were relaxed, then a stable graphene sheet with torsional deformation was obtained. For the PCT-graphene complex, the adsorption model of PCT is parallel adsorption which is proved to be the most stable model by the binding energy calculations (see section 3.1). Figure 3 presents the optimized deformed graphene sheet and the optimized PCT/deformed complex, the torsional angle of graphene sheet is 20° in both structures. All positive frequencies ensured ground state structure of the optimized system. 
Results and Discussion
Structural Propertie
We first optimized the geometry of the H-saturated graphene and PCT molecules. The C-C bond length is 1.412-1.442Å in center region, which is in good agreement with the experiment data 1.42 Å [12] . The structure parameters of the PCT molecule is reported in Table1. It can be seen that the results of our calculations are very close to the literature data (the data with *) [13] . In order to evaluate the interaction of between paracetamol molecule with graphene sheet, the binding energy E b [13] of adsorbed systems was calculated, which is defined as:
E (PCT/Gra) , E (Gra) , E (PCT) denote the total energy of the graphene-paracetamol complex, the graphene sheet and the paracetamol molecule, respectively. The negative E b corresponds to a stable adsorption system. The greater the absolute value of E b , the more stable the adsorbed system. The binding energies of the four models are collected in Table 2 . It was found that the binding energy of the model 4 were the smallest (E b >-40kcal/mol, which indicating physical nature). Therefore, the parallel adsorption of PCT onto graphene is the most stable model. So that, the parallel adsorption model is used in the latter calculations. The bond lengths in the PCT molecule in Model 4 are listed in Table 1 and we found that the graphene has little effect on the PCT geometry. Table 2 gives the binding energies of different PCT-graphene complexes. It was found that the deformation significantly increased the binding energy of the adsorption system. The overall trend is: the larger deformation degree, the larger binding energy. This indicates that the deformation could be used to regulate the binding strength of the PCT and graphene, so that the sustained or controlled release of the drug could be achieved by adjusting the deformation of graphene.
Global reactivity Descriptors
Global hardness (η), energy gap(E g ), chemical potential (E f ), and electrophilicity index(ω) are known as global reactivity descriptors [14] . In order to describe the stability and chemical reactivity of different drug delivery systems, the global reactivity descriptors have been used.
HOMO and LUMO refer to highest occupied molecular orbital and lowest unoccupied molecular orbital. The energy difference between the E LUMO and E HOMO is termed the energy gap E g . The global hardness is defined as:
Hard molecule has a large η (also a large E g ). A large E g means a large excitation energy, so that hard molecules will have their electron density changed more hardly than a soft molecule. Therefore, the global hardness (η) and E g can reflect the stability and chemical activity of a system. The chemical potential (E f ) which shows escape tendency of an electron from equilibrium, is defined as E f =(E LUMO +E HOMO )/2. Electrophilicity index(ω) quantifying the global electrophilic power of the molecule was given by the formula ω=(E f ) 2 /2η. Nucleophilicity (ɛ) is the inverse of the electrophilicity, namely ɛ=1/ω. Table 3 lists global reactivity descriptors of PCT, graphene, deformed graphene sheets and PCT-graphene complexes. From the table 3, it can be seen that compared with pure PCT, the E g and η of PCT-graphene complexes are obviously decreased. Therefore, the global reactivity of PCT-graphene complex is improved, but the stability of PCT-graphene complex is decreased, which may increase the solubility of the drug-graphene complex in body fluids, and be beneficial for the absorption of the drug in the body. From the table 3, we also can see that the value of E g (or η ) gradually becomes small with the increase of the twisted angle, indicating that the graphene becomes more and more unstable, but its activity is getting higher and higher. For the PCT-graphene complex, when the distorted angle is 20°, both E g and η are of the largest values. It indicates that the system is of the highest stability and lowest global reactivity. The global electrophilicity index ω of a drug molecule or a drug-carrier system may be useful in predicting the mechanism of the interaction between them and receptors. From Table 3 , it can be seen that the ω values of graphene sheets and PCT-graphene complexes are obviously larger than that of pure PCT, indicating that graphene can improve the global electrophilicity of PCT-graphene complexes. It is worth mentioning that the global reactivity descriptors cannot describe the local chemical activity. In the next section, we will discuss the local chemical activity of PCT-graphene complexes by the front orbital theory and Fukui index.
Local reactivity Descriptor
According to Frontier Molecular Orbital (FMO) theory, the reaction between an electron-rich specie and an electron-poor specie only involves interaction between HOMO on the electron-rich specie and LUMO on the electron-poor specie. The smaller E g , the more favorable the interaction and the faster the reaction. If the HOMO/LUMO are plotted as contour maps, the region of highest density (regardless of sign) is generally the site of electrophilic/ nucleophilic attack and the site of reaction [15] .
The HOMO/LUMO maps for PCT, graphene and the PCT-deformed graphene complex (distorted angle is 20°) are presented in Figure 4 , the orbital contour value is 0.03. From the Fig.4(a) , we note that the HOMO/LUMO of the PCT is mainly contributed by the benzene ring structure. The LUMO orbitals are mainly anti-bonding molecular orbitals, while the HOMO orbitals are mainly bonding orbitals. This indicates that the reactivity of PCT is mainly guided by benzene ring structure. In addition, it should be noted that the phenolic hydroxyl and peptide HOMO LUMO (a) (b) (c) Figure 4 . Charge density isosurfaces of LUMO and HOM.
For (a) PCT, (b)graphene and (c) PCT/20° deformed graphene system. (Colors of blue and yellow present positive and negative isosurface) chain of PCT also have a certain contribution to the frontier molecular orbitals, thus, they also play a role in the drug activity of PCT. Form  Fig.4(b) , it is clearly seen that graphene sheets are with uniform electron density distribution in the frontier orbitals. The main active site of the PCT molecule is on the benzene ring, and the active sites of graphene have a uniform distribution, this results that there is no preferential adsorption site of PCT on the graphene sheet. This may be the reason why PCT is absorbed parallelly onto the surface of the graphene. From Fig. 4 (c) , we can observe that the majority of the frontier orbitals of the PCT-deformed graphene complex are located on the graphene sheet. It is worth noting that the PCT molecule has almost no contribution to the HOMO and LUMO on the PCT-deformed graphene complex. Consequently, we can conclude that the reactivity of PCT-deformed graphene complex is contributed by the deformed graphene, PCT (absorbed on deformed graphene) has almost lost its drug reactivity. In other word, before PCT is dissolved from PCT/deformed graphene, PCT will not exert its efficacy, this may result in the realization of the controlled efficacy of PCT.
Fukui functions as reactivity descriptors are used to identify the most reactive sites in organic molecules. And they also can indicate the nucleophilic and electrophilic behavior of each molecule. Fukui functions using the Mulliken population analysis (MPA) and the finite difference (FD) approximations approach were calculated using the equations [16] :
where ‫ݍ‬ (ܰ + 1) , ‫ݍ‬ (ܰ) and ‫ݍ‬ (ܰ − 1) stand for the gross charge on atom k of the anion, neutral molecule and positive ion, respectively. ݂ ା and ݂ ି are the Fukui indices measure its electrophilic and nucleophilic tendencies, respectively. It follows that a larger value of ݂ ା 、 ݂ ି corresponds to a better capability of accepting/losing charge. Consequently, according to the Fukui function, the pharmacological activity sites of the drug molecule can be deduced.
The Fukui indices of part of the atoms in PCT molecule are collected in Tables 4. The atomic labels employed in Table 4 are the same as those displayed in Figure 1(b) . From Table  4 , it is clear that O7 and O13 have the largest f -values, so the most likely sites for electrophilic attack are oxygen atoms in hydroxyl and carbonyl groups. In turn, the site for nucleophilic attack is controlled by the value of f + . C11 and O13 have the largest f + value, therefore, the most susceptible sites for nucleophilic attack are oxygen and carbon atoms in carbonyl group. Table 4 . Fukui indices of atoms of PCT. PCT PCT/Grator0°
PCT/Grator5° PCT/Gra-tor10° PCT/Gra-tor15° PCT/Gra-tor20° When the PCT is absorbed onto the graphene sheet, the Fukui indices of all of the atoms in PCT are reduced obviously, but the values of Fukui indices of O7 and O13 in hydroxyl and carbonyl groups are still the largest. Thus, although PCT is loaded on graphene, its pharmacological activity sites are unchanged. However, the activity is decreased obviously. With the increase of the torsional angle of graphene sheet, the Fukui indices of the atoms in the PCT decrease. The torsional angle and the Fukui index are not linearly related, but overall, the influence of the torsional deformation of the graphene on the pharmacological activity of the PCT is very large, PCT molecule almost lose its pharmacological activity.
Conclusions
In this work, we have presented studies of the interaction between the PCT molecule and the graphene sheet. The binding energy calculation results indicate that the interaction is physical and energetically favorable. PCT is parallel to the graphene surface (adsorption energy is -0.079eV). Torsional deformation can adjust the bonding strength between PCT and graphene sheet. When the torsional angle is 20 °, the system is most stable. Thus, by adjusting the torsional angle we may achieve a sustained or controlled release of PCT drug. Global reactivity descriptors show that the stability of PCT-graphene complex decreases and its reactivity increases. Torsional deformation increases the stability of the drug-graphene complex, but reduces the chemical activity. PCT-graphene complex can easily bind to electrophilic groups in vivo. Increased strain decreases the electrophilic ability of PCT-graphene complex. Unfortunately, the global reactivity descriptors reflect the properties of the PCT-graphene complex as a whole other than local activity, which may have reasonably good correlation with the solubility and dispersion of PCT-graphene complex in the body. Thereby, they cannot be used to discuss the pharmacological activity of drug. The analysis of the frontier orbit indicates that the active sites of the PCT locate at benzene ring, phenolic hydroxyl and peptide chain. While the active sites of PCT-graphene complex are mainly concentrated in the graphene sheet with almost no distribution on the PCT molecule, so PCT almost loses its activity in PCT-graphene complex. Hence, we can deduce that the PCT-graphene complex will not exert its efficacy before PCT dissolves out of PCT-graphene complex, this may result in the realization of the controlled efficacy of PCT. Finally, by calculating the Fukui indices, we can see that hydroxyl and carbonyl is the electrophilic active sites of PCT, and carbonyl is its nucleophilic active sites. Graphene and deformation do not alter the activity sites of the PCT molecule but decrease its activity.
